Tempo Scan Pacific Tbk (TSPC) - Total Assets
Based on the latest financial reports, Tempo Scan Pacific Tbk (TSPC) holds total assets worth Rp12.75 Trillion IDR (≈ $747.28 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Tempo Scan Pacific Tbk net assets for net asset value and shareholders' equity analysis.
Tempo Scan Pacific Tbk - Total Assets Trend (2000–2024)
This chart illustrates how Tempo Scan Pacific Tbk's total assets have evolved over time, based on quarterly financial data.
Tempo Scan Pacific Tbk - Asset Composition Analysis
Current Asset Composition (December 2024)
Tempo Scan Pacific Tbk's total assets of Rp12.75 Trillion consist of 70.4% current assets and 29.6% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 35.7% |
| Accounts Receivable | Rp1.67 Trillion | 13.3% |
| Inventory | Rp2.19 Trillion | 17.6% |
| Property, Plant & Equipment | Rp3.29 Trillion | 26.4% |
| Intangible Assets | Rp127.94 Billion | 1.0% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Tempo Scan Pacific Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Tempo Scan Pacific Tbk worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tempo Scan Pacific Tbk's current assets represent 70.4% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 35.7% of total assets in 2024, up from 1.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 20.0% in 2000.
- Asset Diversification: The largest asset category is property, plant & equipment at 26.4% of total assets.
Tempo Scan Pacific Tbk Competitors by Total Assets
Key competitors of Tempo Scan Pacific Tbk based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥31.46 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.15 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Guobang Pharma Ltd
SHG:605507
|
China | CN¥10.58 Billion |
Tempo Scan Pacific Tbk - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.19 | 2.77 | 2.75 |
| Quick Ratio | 2.36 | 2.11 | 1.97 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp6.13 Trillion | Rp5.34 Trillion | Rp3.69 Trillion |
Tempo Scan Pacific Tbk - Advanced Valuation Insights
This section examines the relationship between Tempo Scan Pacific Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.34 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 10.4% |
| Total Assets | Rp12.49 Trillion |
| Market Capitalization | $644.79 Million USD |
Valuation Analysis
Below Book Valuation: The market values Tempo Scan Pacific Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Tempo Scan Pacific Tbk's assets grew by 10.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Tempo Scan Pacific Tbk (2000–2024)
The table below shows the annual total assets of Tempo Scan Pacific Tbk from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp12.49 Trillion ≈ $731.82 Million |
+10.37% |
| 2023-12-31 | Rp11.32 Trillion ≈ $663.06 Million |
-0.12% |
| 2022-12-31 | Rp11.33 Trillion ≈ $663.83 Million |
+17.47% |
| 2021-12-31 | Rp9.64 Trillion ≈ $565.12 Million |
+5.93% |
| 2020-12-31 | Rp9.10 Trillion ≈ $533.50 Million |
+8.74% |
| 2019-12-31 | Rp8.37 Trillion ≈ $490.61 Million |
+6.39% |
| 2018-12-31 | Rp7.87 Trillion ≈ $461.15 Million |
+5.85% |
| 2017-12-31 | Rp7.43 Trillion ≈ $435.66 Million |
+12.89% |
| 2016-12-31 | Rp6.59 Trillion ≈ $385.90 Million |
+4.79% |
| 2015-12-31 | Rp6.28 Trillion ≈ $368.26 Million |
+12.37% |
| 2014-12-31 | Rp5.59 Trillion ≈ $327.71 Million |
+3.42% |
| 2013-12-31 | Rp5.41 Trillion ≈ $316.88 Million |
+16.73% |
| 2012-12-31 | Rp4.63 Trillion ≈ $271.47 Million |
+9.00% |
| 2011-12-31 | Rp4.25 Trillion ≈ $249.06 Million |
+18.41% |
| 2010-12-31 | Rp3.59 Trillion ≈ $210.34 Million |
+10.01% |
| 2009-12-31 | Rp3.26 Trillion ≈ $191.20 Million |
+9.98% |
| 2008-12-31 | Rp2.97 Trillion ≈ $173.86 Million |
+6.99% |
| 2007-12-31 | Rp2.77 Trillion ≈ $162.49 Million |
+11.85% |
| 2006-12-31 | Rp2.48 Trillion ≈ $145.27 Million |
+5.69% |
| 2005-12-31 | Rp2.35 Trillion ≈ $137.45 Million |
+9.54% |
| 2004-12-31 | Rp2.14 Trillion ≈ $125.48 Million |
+10.19% |
| 2003-12-31 | Rp1.94 Trillion ≈ $113.87 Million |
+6.98% |
| 2002-12-31 | Rp1.82 Trillion ≈ $106.44 Million |
+9.17% |
| 2001-12-31 | Rp1.66 Trillion ≈ $97.50 Million |
+16.50% |
| 2000-12-31 | Rp1.43 Trillion ≈ $83.69 Million |
-- |
About Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and… Read more